JP2005526040A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005526040A5 JP2005526040A5 JP2003569190A JP2003569190A JP2005526040A5 JP 2005526040 A5 JP2005526040 A5 JP 2005526040A5 JP 2003569190 A JP2003569190 A JP 2003569190A JP 2003569190 A JP2003569190 A JP 2003569190A JP 2005526040 A5 JP2005526040 A5 JP 2005526040A5
- Authority
- JP
- Japan
- Prior art keywords
- chloride
- cyclooxygenase
- composition according
- inhibitor
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35788802P | 2002-02-19 | 2002-02-19 | |
| PCT/US2003/004561 WO2003070233A1 (en) | 2002-02-19 | 2003-02-14 | Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005526040A JP2005526040A (ja) | 2005-09-02 |
| JP2005526040A5 true JP2005526040A5 (https=) | 2006-03-30 |
Family
ID=27757670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003569190A Abandoned JP2005526040A (ja) | 2002-02-19 | 2003-02-14 | 失禁の治療のためのシクロオキシゲナーゼ阻害剤及び抗ムスカリン剤の使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20030191172A1 (https=) |
| EP (1) | EP1476146A1 (https=) |
| JP (1) | JP2005526040A (https=) |
| KR (1) | KR20050005410A (https=) |
| CN (1) | CN1633283A (https=) |
| AU (1) | AU2003211078A1 (https=) |
| BR (1) | BR0307772A (https=) |
| CA (1) | CA2475374A1 (https=) |
| MX (1) | MXPA04008037A (https=) |
| PL (1) | PL372395A1 (https=) |
| WO (1) | WO2003070233A1 (https=) |
| ZA (1) | ZA200406148B (https=) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1424079A1 (en) * | 2002-11-27 | 2004-06-02 | Boehringer Ingelheim International GmbH | Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine |
| WO2005011683A1 (ja) * | 2003-08-04 | 2005-02-10 | Kyorin Pharmaceutical Co., Ltd. | 経皮吸収型製剤 |
| CZ23088U1 (cs) * | 2004-03-25 | 2011-12-19 | Astellas Pharma Inc. | Kompozice pevného farmaceutického prípravku solifenacinu nebo jeho soli |
| WO2006046560A1 (ja) * | 2004-10-29 | 2006-05-04 | Taiho Pharmaceutical Co., Ltd. | プロピベリン含有経口粉粒状製剤及びその製造法 |
| US20110071204A1 (en) * | 2005-02-03 | 2011-03-24 | Kyorin Pharmaceutical Co., Ltd. | Percutaneous absorption preparation |
| CA2599158C (en) * | 2005-02-25 | 2011-01-25 | Astellas Pharma Inc. | Pharmaceutical agent comprising solifenacin |
| US20070015832A1 (en) * | 2005-07-14 | 2007-01-18 | Myriad Genetics, Incorporated | Methods of treating overactive bladder and urinary incontinence |
| CA2673545A1 (en) * | 2006-12-22 | 2008-07-03 | Recordati Ireland Limited | Combination therapy of lower urinary tract disorders with .alpha.2.delta. ligands and nsaids |
| US9532959B2 (en) | 2010-07-08 | 2017-01-03 | Wellesley Pharmaceuticals, Llc | Pharmaceutical formulation for reducing frequency of urination and method of use thereof |
| US10010514B2 (en) | 2010-07-08 | 2018-07-03 | Wellesley Pharmaceuticals, Llc | Pharmaceutical formulation for reducing frequency of urination and method of use thereof |
| US20120244221A1 (en) * | 2010-07-08 | 2012-09-27 | Wellesley Pharmaceuticals, Llc | Extended-release formulation for reducing the frequency of urination and method of use thereof |
| US9415048B2 (en) | 2010-07-08 | 2016-08-16 | Wellesley Pharmaceuticals, Llc | Pharmaceutical formulation for reducing frequency of urination and method of use thereof |
| US8236857B2 (en) | 2010-07-08 | 2012-08-07 | Wellesley Pharmaceuticals, Llc | Extended-release formulation for reducing the frequency of urination and method of use thereof |
| US20130323288A1 (en) | 2010-07-08 | 2013-12-05 | Wellesley Pharmaceuticals, Llc | Pharmaceutical formulation for bedwetting and method of use thereof |
| US20120237574A1 (en) * | 2010-07-08 | 2012-09-20 | Wellesley Pharmaceuticals, Llc | Delayed-release formulation for reducing the frequency of urination and method of use thereof |
| US9119878B2 (en) | 2010-07-08 | 2015-09-01 | Wellesley Pharmaceuticals, Llc | Extended-release formulation for reducing the frequency of urination and method of use thereof |
| US8236856B2 (en) | 2010-07-08 | 2012-08-07 | Wellesley Pharmaceuticals, Llc | Delayed release formulation for reducing the frequency of urination and method of use thereof |
| CN103191430A (zh) * | 2012-01-04 | 2013-07-10 | 韦尔斯利医药有限公司 | 用于缓解尿频的缓释制剂及其使用方法 |
| US10105330B2 (en) | 2012-01-04 | 2018-10-23 | Wellesley Pharmaceuticals, Llc | Extended, delayed and immediate release formulation method of manufacturing and use thereof |
| BR112014016550A8 (pt) * | 2012-01-04 | 2017-07-04 | Wellesley Pharmaceuticals Llc | formulação de liberação retardada para reduzir a frequência de urinação e método de uso da mesma |
| US10278925B2 (en) | 2012-01-04 | 2019-05-07 | Wellesley Pharmaceuticals, Llc | Delayed-release formulations, methods of making and use thereof |
| CN103191429A (zh) * | 2012-01-04 | 2013-07-10 | 韦尔斯利医药有限公司 | 用于缓解尿频的延长释放制剂及其使用方法 |
| EP2612662B1 (en) * | 2012-01-04 | 2020-03-04 | Wellesley Pharmaceuticals, LLC | Delayed-release formulation for reducing the frequency of urination and method of use thereof |
| MX2014008283A (es) * | 2012-01-04 | 2015-03-03 | Wellesley Pharmaceutical Llc | Formulacion de liberacion prolongada para reducir la frecuencia de orinar y metodos de uso de esta. |
| TWI587879B (zh) * | 2012-01-04 | 2017-06-21 | 魏斯理製藥公司 | 用於減少排尿頻率的延長釋放製劑及其使用方法 |
| EP2612661B1 (en) * | 2012-01-04 | 2020-03-04 | Wellesley Pharmaceuticals, LLC | Delayed release formulation for reducing the frequency of urination and method of use thereof |
| EP2612663A1 (en) * | 2012-01-04 | 2013-07-10 | Wellesley Pharmaceuticals, LLC | Extended-release formulation for reducing the frequency of urination and method of use thereof |
| RU2669565C2 (ru) * | 2012-03-19 | 2018-10-12 | УЭЛЛСЛИ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи | Препарат длительного высвобождения для снижения частоты мочеиспускания и способ его применения |
| CA2875818A1 (en) * | 2012-07-27 | 2014-01-30 | Wellesley Pharmaceuticals, Llc | Pharmaceutical formulation for bedwetting and method of use thereof |
| US10596127B2 (en) | 2013-03-14 | 2020-03-24 | Wellesley Pharmaceuticals, Llc | Composition for reducing the frequency of urination, method of making and use thereof |
| US10792326B2 (en) | 2013-06-28 | 2020-10-06 | Wellesley Pharmaceuticals, Llc | Pharmaceutical formulation for bedwetting and method of use thereof |
| RU2016152226A (ru) * | 2014-06-06 | 2018-07-09 | УЭЛЛСЛИ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи | Фармацевтический состав для уменьшения частоты мочеиспускания и способ его применения |
| US10105328B2 (en) | 2014-06-06 | 2018-10-23 | Wellesley Pharmaceuticals, Llc | Composition for reducing frequency of urination, method of making and use thereof |
| JP7195067B2 (ja) * | 2018-06-20 | 2022-12-23 | 花王株式会社 | ロズマリン酸誘導体又はその塩 |
| JP2020033272A (ja) * | 2018-08-27 | 2020-03-05 | 花王株式会社 | 過活動膀胱の予防又は改善剤 |
| JP7223477B2 (ja) * | 2018-10-10 | 2023-02-16 | 花王株式会社 | Ｔｒｐｖ４活性抑制剤 |
| CN110279863B (zh) * | 2019-07-29 | 2022-02-22 | 牡丹江医学院 | 用于治疗泌尿疾病的药物组合物及其制剂 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5382600A (en) * | 1988-01-22 | 1995-01-17 | Pharmacia Aktiebolag | 3,3-diphenylpropylamines and pharmaceutical compositions thereof |
| IT1288123B1 (it) * | 1996-09-04 | 1998-09-10 | Nicox Sa | Uso di nitroderivati per l'incontinenza urinaria |
| SE9703693D0 (sv) * | 1997-10-10 | 1997-10-10 | Astra Pharma Prod | Novel combination |
| WO2002015902A1 (en) * | 2000-08-23 | 2002-02-28 | Merck & Co., Inc. | Method of treating or preventing urinary incontinence using prostanoid ep1 receptor antagonists |
| PE20020547A1 (es) * | 2000-10-24 | 2002-06-12 | Upjohn Co | Uso de la tolterodina en tratamientos del asma |
| ITMI20010733A1 (it) * | 2001-04-05 | 2002-10-05 | Recordati Chem Pharm | Uso di inibitori dell'isoenzina cox-2 per il trattamento dell'incontinenza urinaria |
-
2003
- 2003-02-14 KR KR10-2004-7012795A patent/KR20050005410A/ko not_active Ceased
- 2003-02-14 PL PL03372395A patent/PL372395A1/xx not_active Application Discontinuation
- 2003-02-14 CN CNA03804160XA patent/CN1633283A/zh active Pending
- 2003-02-14 JP JP2003569190A patent/JP2005526040A/ja not_active Abandoned
- 2003-02-14 MX MXPA04008037A patent/MXPA04008037A/es not_active Application Discontinuation
- 2003-02-14 EP EP03742765A patent/EP1476146A1/en not_active Ceased
- 2003-02-14 WO PCT/US2003/004561 patent/WO2003070233A1/en not_active Ceased
- 2003-02-14 AU AU2003211078A patent/AU2003211078A1/en not_active Abandoned
- 2003-02-14 BR BR0307772-1A patent/BR0307772A/pt not_active IP Right Cessation
- 2003-02-14 CA CA002475374A patent/CA2475374A1/en not_active Abandoned
- 2003-02-18 US US10/368,091 patent/US20030191172A1/en not_active Abandoned
-
2004
- 2004-08-02 ZA ZA200406148A patent/ZA200406148B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005526040A5 (https=) | ||
| ZA200406148B (en) | Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence | |
| US20090264530A1 (en) | Combined nsaid and acetaminophen formulation and method | |
| KR100444195B1 (ko) | 시너지 효과를 위한 오피오이드 진통제와싸이클로옥시게나아제-2 저해제의 진통제 조합 | |
| AU2004224322A2 (en) | Methods of treating lower urinary tract disorders using smooth muscle modulators and alpha-2-delta subunit calcium channel modulators | |
| JP2006509752A5 (https=) | ||
| JP2007512273A5 (https=) | ||
| JP2010535802A5 (https=) | ||
| JP2023143940A5 (https=) | ||
| AU2004207010A2 (en) | Methods of treating lower urinary tract disorders using sodium channel modulators | |
| JP2013516488A (ja) | 炭酸脱水酵素阻害薬およびさらなる活性剤の組み合わせによる閉塞型睡眠時無呼吸症候群の治療 | |
| CN1625411A (zh) | Nsaid与pde－4抑制剂的并用药物 | |
| US20050119239A1 (en) | Pharmaceutical composition consisting of a beta-3-adrenoceptor agonist and an active substance which influences prostaglandin metabolism | |
| ES2367881T3 (es) | Politerapia para trastornos de las vías urinarias inferiores con ligandos a2d y los aine. | |
| WO2010120253A1 (en) | Thiocolchicoside and non-steroidal anti-inflammatory drug combinations | |
| WO2023155837A1 (zh) | 具有镇痛和/或止痒功能的药物组合物及其用途 | |
| AR041069A1 (es) | Composicion de tolterodina liquida oral | |
| JP2006104186A (ja) | 感冒用医薬組成物 | |
| Halen et al. | Synthesis and Pharmacological Evaluation of Some Dual‐Acting Amino‐alcohol Ester Derivatives of Flurbiprofen and 2‐[1, 1′‐Biphenyl‐4‐yl] acetic Acid: A Potential Approach to Reduce Local Gastrointestinal Toxicity | |
| US20130142869A1 (en) | Compositions Comprising Non Steroidal Anti-inflammatory Drugs and Methods for Use Thereof | |
| JP2006515607A5 (https=) | ||
| US20090264454A1 (en) | Combined hydrocodone and analgesic formulation and method | |
| Izzo et al. | Recent acquisitions in pain therapy: meclofenamic acid | |
| Rodríguez | Antagonism of tremorine-induced tremor by serotoninergic agents in mice. Interactions with levodopa. | |
| JPWO2021142288A5 (ja) | ナルブフィン治療可能障害を治療するために投与されるナルブフィン製剤 |